Cerebrolysin 60mg
Size: 60mg | 99% Purity
M.Wt: Complex mixture
Formula: Neuropeptide complex
Solubility: H2O
Purity: >99%
Storage: -20°C / 3 years
Half life: Variable
| Purity (HPLC) | >99% |
|---|---|
| Synonyms | Cerebrolysin, FPE |
| Solubility | H2O |
| Storage | -20°C / 3 years |
HPLC and MS verified by UKAS-accredited laboratories.
Royal Mail 24 and DPD Next Day options.
COA and batch number on every vial.
Description
Size: 60mg | 99% Purity
M.Wt: Complex mixture
Formula: Neuropeptide complex
Solubility: H2O
Purity: >99%
Storage: -20°C / 3 years
Half life: Variable
Reconstitution
For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.
Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.
-
Cerebrolysin for acute ischaemic stroke.
Ziganshina LE et al. · The Cochrane database of systematic reviews · 2023
PubMed PMID 37818733 -
Cerebrolysin for vascular dementia.
Cui S et al. · The Cochrane database of systematic reviews · 2019
PubMed PMID 31710397 -
Cerebrolysin for acute ischaemic stroke.
Ziganshina LE et al. · The Cochrane database of systematic reviews · 2020
PubMed PMID 32662068
You may also need
Related compounds
